NLS Pharmaceutics Ltd. (NASDAQ:NLSP – Get Free Report)’s share price was down 0.4% during mid-day trading on Wednesday . The stock traded as low as $2.20 and last traded at $2.28. Approximately 108,799 shares changed hands during mid-day trading, a decline of 98% from the average daily volume of 4,439,447 shares. The stock had previously closed at $2.29.
NLS Pharmaceutics Price Performance
The firm’s 50-day simple moving average is $2.08 and its 200-day simple moving average is $2.25.
About NLS Pharmaceutics
NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).
See Also
- Five stocks we like better than NLS Pharmaceutics
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- What is diluted earnings per share (Diluted EPS)?
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- How to Buy Cheap Stocks Step by Step
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for NLS Pharmaceutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NLS Pharmaceutics and related companies with MarketBeat.com's FREE daily email newsletter.
